JOHN HOPE FRANKLIN CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.duke.edu
Telephone Enhancement Procedure for Continuing Care - 1
Phase 3
Completed
- Conditions
- Substance-Related Disorders
- First Posted Date
- 2003-08-13
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- Duke University
- Target Recruit Count
- 339
- Registration Number
- NCT00067171
- Locations
- 🇺🇸
Julian F. Keith, Black Mountain, North Carolina, United States
🇺🇸James Gilmore Jr. Treatment Center, Kalamazoo, Michigan, United States
🇺🇸Walter B. Jones, ADATC, Greenville, North Carolina, United States
Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
Phase 2
Withdrawn
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2003-08-11
- Last Posted Date
- 2013-03-28
- Lead Sponsor
- Duke University
- Registration Number
- NCT00046878
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
Phase 1
Terminated
- Conditions
- Prostate Cancer
- First Posted Date
- 2003-07-30
- Last Posted Date
- 2013-03-21
- Lead Sponsor
- Duke University
- Target Recruit Count
- 3
- Registration Number
- NCT00010127
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers
Phase 1
Completed
- Conditions
- Metastatic CancerBrain and Central Nervous System Tumors
- First Posted Date
- 2003-07-08
- Last Posted Date
- 2014-07-16
- Lead Sponsor
- Duke University
- Registration Number
- NCT00002752
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Biological Therapy in Treating Patients With Advanced Cancer
Not Applicable
Completed
- Conditions
- Breast CancerOvarian CancerGastric Cancer
- First Posted Date
- 2003-05-21
- Last Posted Date
- 2014-07-09
- Lead Sponsor
- Duke University
- Target Recruit Count
- 3
- Registration Number
- NCT00005956
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Immunotherapy in Treating Patients With Metastatic Breast Cancer
Phase 1
Terminated
- Conditions
- Breast Cancer
- Interventions
- Biological: carcinoembryonic antigen RNA-pulsed DC cancer vaccine
- First Posted Date
- 2003-04-25
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Duke University
- Target Recruit Count
- 4
- Registration Number
- NCT00003432
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer
Phase 1
Completed
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Biological: CEA peptide 1-6D
- First Posted Date
- 2003-04-09
- Last Posted Date
- 2014-09-08
- Lead Sponsor
- Duke University
- Target Recruit Count
- 4
- Registration Number
- NCT00057915
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Coping Skills Training for Early Rheumatoid Arthritis
Not Applicable
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- Behavioral: Comprehensive Coping Skills TrainingBehavioral: Arthritis Education SessionsBehavioral: Standard Care
- First Posted Date
- 2003-03-12
- Last Posted Date
- 2018-10-25
- Lead Sponsor
- Duke University
- Target Recruit Count
- 105
- Registration Number
- NCT00056394
- Locations
- 🇺🇸
Duke University, Durham, North Carolina, United States
🇺🇸Duke University Medical Center, Durham, North Carolina, United States
Weight Loss Maintenance (WLM)
Not Applicable
Completed
- Conditions
- Cardiovascular DiseasesHeart DiseasesObesityDiabetes Mellitus, Non-insulin DependentHypertension
- Interventions
- Behavioral: Personal contact (PC)Behavioral: Interactive technology (IT)
- First Posted Date
- 2003-02-14
- Last Posted Date
- 2012-03-07
- Lead Sponsor
- Duke University
- Target Recruit Count
- 1685
- Registration Number
- NCT00054925
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors
Phase 1
Completed
- Conditions
- NeuroblastomaBrain and Central Nervous System TumorsMetastatic Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2014-08-21
- Lead Sponsor
- Duke University
- Registration Number
- NCT00003461
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath